Baker Brothers Advisors - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 69 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q1 2021$2,646,000
-62.2%
461,726
-41.0%
0.01%
-57.7%
Q4 2020$6,993,000
+30.2%
782,183
+69.6%
0.03%
+23.8%
Q3 2020$5,370,000
-31.0%
461,324
-5.0%
0.02%
-38.2%
Q2 2020$7,785,000
+729.1%
485,624
+209.8%
0.03%
+466.7%
Q1 2020$939,000
-54.6%
156,7730.0%0.01%
-45.5%
Q4 2019$2,069,000
+6.3%
156,7730.0%0.01%
-15.4%
Q3 2019$1,947,000
-22.9%
156,7730.0%0.01%
-23.5%
Q2 2019$2,524,000
-48.8%
156,7730.0%0.02%
-46.9%
Q1 2019$4,934,000
-4.2%
156,7730.0%0.03%
-23.8%
Q4 2018$5,148,000
-28.7%
156,773
-33.4%
0.04%
-12.5%
Q3 2018$7,216,000
+14.5%
235,2940.0%0.05%
+2.1%
Q2 2018$6,304,000235,2940.05%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,300,000$17,160,0002.55%
Alphabet Inc. 699,352$9,231,0000.56%
DAFNA Capital Management LLC 100,000$1,320,0000.45%
JUPITER ASSET MANAGEMENT LTD 705,356$9,311,0000.29%
Artal Group S.A. 500,000$6,600,0000.26%
Cormorant Asset Management, LP 479,988$6,336,0000.25%
MPM BioImpact LLC 39,740$525,0000.19%
Granahan Investment Management 305,158$4,028,0000.18%
Burrage Capital Management LLC 13,113$173,0000.12%
Vident Investment Advisory, LLC 118,866$1,569,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders